Search results
Results From The WOW.Com Content Network
This is a list of products manufactured by the multinational pharmaceutical, biologics, and vaccines manufacturing company GSK. Pharmaceutical products [ edit ] This list is complete and up to date as of October 2023 .
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [4] [5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith ...
3 Largest selling pharmaceutical products of 2015. 4 Best selling pharmaceuticals of 2013. 5 See also. 6 References. ... GlaxoSmithKline: 5,227 (778) 12 Rosuvastatin ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
US lawmakers in January had criticized the top four inhalers manufacturers — AstraZeneca, Boehringer, Teva Pharmaceuticals and GSK — over high prices, and launched an investigation to look ...
Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...
The drug is among a dozen significant product releases that GSK anticipates in the coming years. The company has shifted its HIV focus to long-acting treatments and prevention therapies, amid a ...